Brief: Radiopharm Theranostics Says Entered Into Clinical Supply Agreement
26/10/2022 02:43
Oct 26 (Reuters) - Radiopharm Theranostics Ltd RAD.AX :
* ENTERED INTO CLINICAL SUPPLY AGREEMENT THAT WILL SEE
NORTHSTAR
SUPPLY RADIOPHARM WITH ACTINIUM-225
* INITIAL ORDER WITH NORTHSTAR EXPECTED TO OCCUR DURING
FIRST HALF
OF 2024
* COSTS ASSOCIATED WITH PURCHASE OF ACTINIUM-225 NOT
MATERIAL FOR
CO'S ANNUAL BUDGETED EXPENDITURE
Source text for Eikon: ID:nASX9djC8p
Further company coverage: RAD.AX
Recent news on Radiopharm Theranostics
See all newsBrief: Radiopharm Theranostics Advances To Cohort 3 In 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial
Brief: Radiopharm Theranostics And Siemens Healthineers Sign Clinical Supply Agreement For Rad101 In The U.S.
Brief: Radiopharm Theranostics Says RAD And Siemens Sign Clinical Supply Agreement For Rad101
Brief: Radiopharm Theranostics Doses First Patient In Phase 1/2A Clinical Study Of Betabart
Brief: Radiopharm Theranostics Says Co Increases Ownership In Radiopharm Ventures To 87.5%